- $835.21m
- $574.56m
- $333.79m
- 81
- 54
- 73
- 80
Annual income statement for CareDx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 192 | 296 | 322 | 280 | 334 |
| Cost of Revenue | |||||
| Gross Profit | 129 | 199 | 210 | 178 | 224 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 210 | 326 | 399 | 482 | 293 |
| Operating Profit | -17.7 | -29.7 | -77.2 | -201 | 40.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.8 | -32.1 | -76.2 | -190 | 52.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -18.7 | -30.7 | -76.6 | -190 | 52.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -18.7 | -30.7 | -76.6 | -190 | 52.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.7 | -30.7 | -76.6 | -190 | 52.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.47 | -0.587 | -1.44 | -2.36 | -0.157 |